The Supreme Court Is Paying Attention To Patent Law Again

Law360, New York (April 1, 2013, 11:54 AM EDT) -- The U.S. Supreme Court's decision in Mayo v. Prometheus surprised many patent practitioners with both its reasoning and its expected impact in a fast developing industry. Yet, a close look at Justice Stephen Breyer's dissent from the denial of certiorari in Lab. Corp. in 2006 renders that surprise curious. Indeed, Justice Breyer had put the legal field on notice that the Supreme Court was paying attention to patent eligibility well before seemingly eliminating medical diagnostic patents with Prometheus. With Myriad V to be heard this term, the Supreme Court may further impact the future of patents supporting this field, as it addresses the patentability of isolated DNA sequences....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!